These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2892582

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of hydrochlorothiazide and hydrochlorothiazide plus bevantolol in hypertension.
    Lucas CP, Morledge JH, Tessman DK.
    Clin Ther; 1985; 8(1):49-60. PubMed ID: 2870810
    [Abstract] [Full Text] [Related]

  • 3. Hemodynamic and adrenergic responses of bevantolol and propranolol in hypertensives.
    Snedden W, Fernandez PG, Vasdev S, Bolli P.
    Can J Cardiol; 1989; 5(1):37-41. PubMed ID: 2563955
    [Abstract] [Full Text] [Related]

  • 4. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hemodynamic and neurohumoral factors in the response of hypertensives to hydrochlorothiazide therapy.
    Fernandez PG, Snedden W, Nath C, Vasdev S, Lee C, Darke A.
    Clin Invest Med; 1987 Nov; 10(6):513-9. PubMed ID: 3326694
    [Abstract] [Full Text] [Related]

  • 7. [The anti-hypertensive effect of timolol maleate (blocadren) in gradated combination with a diuretic].
    Vorburger C.
    Schweiz Med Wochenschr; 1976 Oct 23; 106(43):1474-81. PubMed ID: 1013666
    [Abstract] [Full Text] [Related]

  • 8. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP, Weinberger MH, Gavras H, Gavras I, Brown TS, Deterding J, Klotman PE.
    J Clin Hypertens; 1987 Dec 23; 3(4):579-88. PubMed ID: 3330988
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.
    J Hum Hypertens; 2002 Jan 23; 16(1):13-9. PubMed ID: 11840225
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W, Wilson T.
    Clin Invest Med; 1998 Jun 23; 21(3):142-50. PubMed ID: 9627768
    [Abstract] [Full Text] [Related]

  • 14. [Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives].
    Weisser B, Vetter H, Mengden T.
    Dtsch Med Wochenschr; 2003 Mar 14; 128(11):541-4. PubMed ID: 12635025
    [Abstract] [Full Text] [Related]

  • 15. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M, Richter WO, Schwandt P, Holzgreve H.
    Int J Clin Pharmacol Ther; 1997 Jun 14; 35(6):231-4. PubMed ID: 9208337
    [Abstract] [Full Text] [Related]

  • 16. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B.
    Curr Med Res Opin; 2001 Jun 14; 17(1):8-17. PubMed ID: 11464450
    [Abstract] [Full Text] [Related]

  • 17. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD, Binstok G, Mullane JF, Woods JW, Pittman AW, del Greco F, Huang C, Morledge JH.
    Clin Ther; 1983 Jun 14; 5(5):525-39. PubMed ID: 6352036
    [Abstract] [Full Text] [Related]

  • 18. Prazosin in hypertension. Part I. Clinical experience in 100 patients.
    Turner AS, Watson OF, Brocklehurst JE.
    N Z Med J; 1977 Sep 28; 86(596):282-5. PubMed ID: 24193
    [Abstract] [Full Text] [Related]

  • 19. Studies with prazosin--a new effective hypotensive agent. III. An acute double-blind cross-over study comparing the effects of single doses of prazosin and hydrallazine in combination with propranolol and a diuretic.
    Hua AS, Myers JB, Kincaid-Smith P.
    Med J Aust; 1978 Jan 14; 1(1):45-8. PubMed ID: 368538
    [Abstract] [Full Text] [Related]

  • 20. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E, Anson O, Neumann L.
    Am J Hypertens; 1996 Dec 14; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.